Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 61,480 | reported | 19 Mar 2026 | tx 58+468,875−149,889 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4,330 | 68.71 USD | |
| 17 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4,286 | 69.42 USD | |
| 19 Mar 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4,440 | 67.00 USD | |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 26,482 | — | |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 4,790 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8,148 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8,020 | 0.00 USD | deriv |
| 15 Mar 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 5,524 | 0.00 USD | deriv |
| 05 Mar 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 30,724 | 0.00 USD | deriv |
| 05 Mar 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 19,306 | 0.00 USD | deriv |
| 09 Jun 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 17,500 | 43.76 USD | |
| 20 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 3,365 | 50.11 USD | |
| 18 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 3,643 | 46.29 USD | |
| 19 Mar 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 3,557 | 47.40 USD | |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 20,957 | — | |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8,019 | 0.00 USD | deriv |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8,148 | 0.00 USD | deriv |
| 15 Mar 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 4,790 | 0.00 USD | deriv |
| 05 Mar 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 22,098 | 0.00 USD | deriv |
| 05 Mar 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 33,691 | 0.00 USD | deriv |
| 18 Mar 2024 | SALE | Tarsus Pharmaceuticals, Inc. | 4,766 | 30.60 USD | |
| 15 Mar 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 12,938 | — | |
| 15 Mar 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8,148 | 0.00 USD | deriv |
| 15 Mar 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 4,790 | 0.00 USD | deriv |
| 07 Mar 2024 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 32,079 | 0.00 USD | deriv |